Clinical trial
Imaging Modalities for Melanoma Screening and Diagnosis
NCT03699995 is registered in ClinicalTrials.gov with OHSU Knight Cancer Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Imaging Modalities for Melanoma Screening and Diagnosis
- Lead sponsor
- OHSU Knight Cancer Institute
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- May 18, 2018
- Completion date
- December 31, 2025
- Enrollment
- 17 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cutaneous melanoma, melanocytic nevus, skin carcinoma